Choate recently represented Symbiotix Biotherapies, Inc. (Symbiotix), a pioneering microbiome company developing novel molecular therapeutics based on the human microbiome, in its recent equity financing from…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now